106 related articles for article (PubMed ID: 9182265)
21. Renal involvement in monoclonal (type I) cryoglobulinemia: two cases associated with IgG3 kappa cryoglobulin.
Karras A; Noël LH; Droz D; Delansorne D; Saint-André JP; Aucouturier P; Alyanakian MA; Grünfeld JP; Lesavre P
Am J Kidney Dis; 2002 Nov; 40(5):1091-6. PubMed ID: 12407656
[TBL] [Abstract][Full Text] [Related]
22. Prognosis, treatment and outcome of childhood mesangiocapillary (membranoproliferative) glomerulonephritis.
Cansick JC; Lennon R; Cummins CL; Howie AJ; McGraw ME; Saleem MA; Tizard EJ; Hulton SA; Milford DV; Taylor CM
Nephrol Dial Transplant; 2004 Nov; 19(11):2769-77. PubMed ID: 15385635
[TBL] [Abstract][Full Text] [Related]
23. Idiopathic lobular glomerulonephritis (nodular mesangial sclerosis): a distinct diagnostic entity.
Alpers CE; Biava CG
Clin Nephrol; 1989 Aug; 32(2):68-74. PubMed ID: 2766585
[TBL] [Abstract][Full Text] [Related]
24. Long-term follow-up of type II membranoproliferative glomerulonephritis in two children.
Iitaka K; Nakamura S; Moriya S; Koshino H; Iwasaki N; Motoyama O; Sakai T
Clin Exp Nephrol; 2003 Mar; 7(1):58-62. PubMed ID: 14586745
[TBL] [Abstract][Full Text] [Related]
25. Early recurrence of dense deposit disease with marked endocapillary proliferation after renal transplantation.
Aita K; Ito S; Tanabe K; Toma H; Yamaguchi Y; Nagata M
Pathol Int; 2006 Feb; 56(2):101-9. PubMed ID: 16445823
[TBL] [Abstract][Full Text] [Related]
26. Patient with diffuse mesangial and endocapillary proliferative glomerulonephritis with hypocomplementemia and elevated anti-streptolysin O treated with prednisolone, angiotensin-converting enzyme inhibitor, and angiotensin II receptor antagonist.
Ito S; Kuriyama H; Iino N; Iguchi S; Shimada H; Ueno M; Narita I; Nakano M; Nishi S; Karasawa R; Gejyo F
Clin Exp Nephrol; 2003 Dec; 7(4):290-5. PubMed ID: 14712359
[TBL] [Abstract][Full Text] [Related]
27. [Clinical and pathological features of type I and III membranoproliferative glomerulonephritis].
Chen HP; Li LS; Bai XY
Zhonghua Nei Ke Za Zhi; 1992 May; 31(5):293-6, 318. PubMed ID: 1478129
[TBL] [Abstract][Full Text] [Related]
28. Recurrent type III membranoproliferative glomerulonephritis after kidney transplantation.
Morales JM; Martinez MA; Muñoz de Bustillo E; Muñoz MA; Gota R; Usera G
Transplantation; 1997 Apr; 63(8):1186-8. PubMed ID: 9133484
[TBL] [Abstract][Full Text] [Related]
29. The consequences for renal function of the glomerular deposition of PAS positive material in proliferative glomerulopathies. A quantitative study.
Danilewicz M; Wagrowska-Danilewicz M
Gen Diagn Pathol; 1997 Dec; 143(4):225-30. PubMed ID: 9489955
[TBL] [Abstract][Full Text] [Related]
30. Outcome of patients with primary immune-complex type mesangiocapillary glomerulonephritis (MCGN) in Cape Town South Africa.
Okpechi IG; Dlamini TA; Duffield M; Rayner BL; Moturi G; Swanepoel CR
PLoS One; 2014; 9(11):e113302. PubMed ID: 25411791
[TBL] [Abstract][Full Text] [Related]
31. Type of immune and complement deposits and response of immunosuppressive treatment on Membranoproliferative Glomerulonephritis -- a single centre experience.
Imtiaz S; Dhrolia MF; Nasir K; Salman B; Ahmad A
J Pak Med Assoc; 2015 Sep; 65(9):995-1000. PubMed ID: 26338748
[TBL] [Abstract][Full Text] [Related]
32. Mesangiocapillary glomerulonephritis in Down's syndrome.
Gupta SK; Venkataseshan VS; Churg J
Am J Nephrol; 1991; 11(2):112-7. PubMed ID: 1835296
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 children.
Ozdamar SO; Gucer S; Tinaztepe K
Pediatr Nephrol; 2003 Jan; 18(1):23-8. PubMed ID: 12488986
[TBL] [Abstract][Full Text] [Related]
34. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.
Licht C; Fremeaux-Bacchi V
Thromb Haemost; 2009 Feb; 101(2):271-8. PubMed ID: 19190809
[TBL] [Abstract][Full Text] [Related]
35. Apoptosis in lupus SLE-N IV and non-lupus mesangiocapillary glomerulonephritis type I MCGN. I. A comparative study.
Wagrowska-Danilewicz M; Danilewicz M
J Nephrol; 1998; 11(1):44-9. PubMed ID: 9561485
[TBL] [Abstract][Full Text] [Related]
36. Membranoproliferative injury pattern in a renal allograft.
Gökden N; Rossini M; Kumar J; Fogo AB
Am J Kidney Dis; 2005 Sep; 46(3):573-6. PubMed ID: 16129221
[No Abstract] [Full Text] [Related]
37. [Onset of glomerulonephritis after insect's bite].
Ianushkevich TN; Kukhtevich AV; Kireeva VI
Ter Arkh; 1998; 70(6):54-5. PubMed ID: 9695229
[No Abstract] [Full Text] [Related]
38. Hereditary nephritis mimicking immune complex-mediated glomerulonephritis.
Nasr SH; Markowitz GS; Goldstein CS; Fildes RD; D'Agati VD
Hum Pathol; 2006 May; 37(5):547-54. PubMed ID: 16647952
[TBL] [Abstract][Full Text] [Related]
39. [Ocular impairment during type II membranoproliferative glomerulonephritis].
Lahbil D; Rais L; Hamdani M; El Kettani A; Laouissi N; Zaghloul K; Amraoui A
J Fr Ophtalmol; 2002 Nov; 25(9):949-54. PubMed ID: 12515943
[TBL] [Abstract][Full Text] [Related]
40. Recurrent type I membranoproliferative glomerulonephritis in a renal allograft: successful treatment with plasmapheresis.
Saxena R; Frankel WL; Sedmak DD; Falkenhain ME; Cosio FG
Am J Kidney Dis; 2000 Apr; 35(4):749-52. PubMed ID: 10739799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
